NCT06663787 2026-04-13
HER2 CR
Nagoya City University
Active not recruiting
Clinical Trials
24 trialsNCT07416409 2026-02-18
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
Deraya University
Completed
NCT03199300 2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
NCT03738553 2025-10-29
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
University of Washington
Active not recruiting
NCT07009600 2025-06-06
Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer
Samsung Medical Center
Completed
NCT05525858 2025-04-27
KOSMOSII
Seoul National University Bundang Hospital
Recruiting
NCT05572645 2024-02-26
Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab
Fudan University
Completed
NCT05912062 2023-09-29
BiOnHER
Institut Català d'Oncologia
Unknown
NCT05931042 2023-07-05
Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review
Rawalpindi Medical College
Completed
NCT05030519 2022-03-02
A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer
Zhejiang Cancer Hospital
Unknown
NCT05177666 2022-01-04
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
The University of Hong Kong-Shenzhen Hospital
Unknown
NCT05131893 2021-11-23
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Not yet recruiting
NCT04962425 2021-07-15
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Peking University Third Hospital
Unknown
NCT04961307 2021-07-14
Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab
Peking University Third Hospital
Unknown
NCT04683445 2020-12-24
Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT04609540 2020-12-16
Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
Shandong Cancer Hospital and Institute
Unknown
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT00875238 2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
NCT03390608 2018-01-04
Prognostic and Predictive Factors for Small Breast Tumors
Karolinska Institutet
Completed
NCT00755313 2017-11-24
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco
Completed
NCT03024450 2017-01-24
Trastuzumab Based Therapy in HER2 Positive AGC
Shanghai Zhongshan Hospital
Completed
NCT02656589 2016-10-13
microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT00795678 2013-08-02
Chemotherapeutic Agents in Brain/Breast
Case Comprehensive Cancer Center
Completed
NCT01894711 2013-07-10
Real World Efficiency of Trastuzumab in Early Breast Cancer
Maastricht University Medical Center
Completed